078054814 | TMEAH | 63511491 | | 2711793 | 5/30/2006 12:00:00 AM | CHF exacerbation | | DIS | Admission Date : 5/28/2006 Report Status : Discharge Date : 8/13/2006 ****** FINAL DISCHARGE ORDERS ****** KAI , KEITH 284-98-55-6 O A Do Service : CAR DISCHARGE PATIENT ON : 8/27/06 AT 03:00 PM CONTINGENT UPON HO evaluation WILL D/C ORDER BE USED AS THE D/C SUMMARY : YES Attending : WENSKOSKI , STANTON SID , M.D. CODE STATUS : Full code DISPOSITION : Home w / services DISCHARGE MEDICATIONS : ECASA 81 MG PO DAILY Starting Today -LRB- 6/28 -RRB- Override Notice : Override added on 4/24/06 by BRINKMANN , ROLANDO , M.D. on order for COUMADIN PO -LRB- ref # 832488821 -RRB- POTENTIALLY SERIOUS INTERACTION : ASPIRIN & WARFARIN Reason for override : ok LIPITOR -LRB- ATORVASTATIN -RRB- 40 MG PO BEDTIME Alert overridden : Override added on 8/27/06 by : POTENTIALLY SERIOUS INTERACTION : ERYTHROMYCIN & ATORVASTATIN CALCIUM Reason for override : home DIGOXIN 0.25 MG PO DAILY Starting Today -LRB- 6/28 -RRB- Override Notice : Override added on 4/24/06 by HEIMERDINGER , NOEL , M.D. on order for ERYTHROMYCIN OPHTHALMIC OINTMENT OU -LRB- ref # 845794197 -RRB- SERIOUS INTERACTION : DIGOXIN & ERYTHROMYCIN Reason for override : ok LASIX -LRB- FUROSEMIDE -RRB- 80 MG PO DAILY Starting IN AM -LRB- 6/28 -RRB- INSULIN NPH HUMAN 40 UNITS QAM ; 30 UNITS QPM SC 40 UNITS QAM 30 UNITS QPM IMDUR ER -LRB- ISOSORBIDE MONONITRATE -LRB- SR -RRB- -RRB- 30 MG PO DAILY Food/Drug Interaction Instruction Give on an empty stomach -LRB- give 1hr before or 2hr after food -RRB- LISINOPRIL 10 MG PO DAILY Alert overridden : Override added on 8/27/06 by : POTENTIALLY SERIOUS INTERACTION : SPIRONOLACTONE & LISINOPRIL POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & LISINOPRIL POTENTIALLY SERIOUS INTERACTION : POTASSIUM CHLORIDE & LISINOPRIL Reason for override : MD aware TOPROL XL -LRB- METOPROLOL SUCCINATE EXTENDED RELEASE -RRB- 25 MG PO DAILY Starting IN AM -LRB- 6/28 -RRB- Food/Drug Interaction Instruction Take consistently with meals or on empty stomach . 
Number of Doses Required -LRB- approximate -RRB- : 1 ALDACTONE -LRB- SPIRONOLACTONE -RRB- 12.5 MG PO DAILY Food/Drug Interaction Instruction Give with meals Override Notice : Override added on 3/8/06 by KRIEG , OLEN , M.D. on order for LISINOPRIL PO 10 MG QD -LRB- ref # 386246762 -RRB- POTENTIALLY SERIOUS INTERACTION : SPIRONOLACTONE & LISINOPRIL Reason for override : aware Previous override information : Override added on 4/24/06 by GLAZNER , LORENZO , M.D. POTENTIALLY SERIOUS INTERACTION : LISINOPRIL & SPIRONOLACTONE SERIOUS INTERACTION : POTASSIUM CHLORIDE & SPIRONOLACTONE Reason for override : ok DIET : Fluid restriction DIET : House / Low chol/low sat . 
fat DIET : House / ADA 1800 cals/dy ACTIVITY : Resume regular exercise FOLLOW UP APPOINTMENT -LRB- S -RRB- : Dr. Chauncey Patock -LRB- CH Cardiology -RRB- 1/21/06 at 4:40 pm scheduled , Dr. Burl Banowski -LRB- PCP -RRB- to be seen in next 2 weeks , Talpaz Cum-ope Enwill Medical Center Endocrinology - you will be contacted on monday 4/12 for an appointmen , ALLERGY : Penicillins ADMIT DIAGNOSIS : CHF exacerbation PRINCIPAL DISCHARGE DIAGNOSIS ; Responsible After Study for Causing Admission -RRB- CHF exacerbation OTHER DIAGNOSIS ; Conditions , Infections , Complications , affecting Treatment/Stay CARDIOMYOPATHY-EF 35 % , ASTHMA , CAD , HTN , hx ETOH ABUSE , INSULIN REQ TYPE II DM OPERATIONS AND PROCEDURES : 8/6 Left Heart Catherization 9/29 Right Heart Catherization Please see hospital course for salient details . 
OTHER TREATMENTS/PROCEDURES -LRB- NOT IN O.R. -RRB- none BRIEF RESUME OF HOSPITAL COURSE : ** CC / ADMIT Dx : SOB ** BRIEF HPI : 45M with non-DCM -LRB- EF25 % -RRB- , DM2 , HTN p/w CHF exacerbation / hypoxia -LRB- PND , dyspnea , cough , ? 
chest tightness on AM of admit -RRB- likely 2/2 to dietary indiscretion and medical noncompliance . 
Treated with lasix , aldactone , ACE , with improvement from NRB to 2L by NC . 
** RELEVANT PMHX : - DCM -LRB- EtOH -RRB- EF 20-25 % -LRB- 5/27 -RRB- followed by Dr. Long Stvrestil s/p angiography 1995 with 50 % LAD -LRB- no intervention -RRB- - HTN - DMII - OSA on CPAP - Asthma ** ALLERGIES : PCN -LRB- rash -RRB- ** HOME MEDS : Lipitor 20 , Dig 0 . 
l25 , ASA , Lasix 80 , Glipizide 5 , Metformin 500 TID , Insulin 70/30 40 QAM/30 QPM , Lisinopril 10 , Toprol 25 , Aldaction 25 , Coumadin 5 ** DAILY STATUS/EXAM : VS 5/14 AF , P70-100 , BP90-110 / 60-70 , O2 94 on RA PULM : CTA CV : JVP 8 , distant , RRR , no murmurs noted ABD : S/NT/ND EXTR : 1 + edema to mid-calf bilat , warm , 2 + pulses NEURO : AOx3 , non-focal ** TESTS/PROCEDURES : 8/6 LHC showed worsening 3vd from prior , no intervention RHC releaved elevated left and right filling pressures , no transpulmonary gradient . 
** CONSULTS : ACE , SS , nutrition ** Hospital Course : CV/I : Patient was sucessfully ruled out by serial enzymes for a potential myocardial infarction . 
The patient was continuedon his home ASA , statin , and BB during his hospital course . 
To rule out concern for ischemia as a role in the deterioration of his cardiomyopathy , a left heart catheterization was performed which showed worsening CAD from his prior study 5 years . 
The patient has 3vd disease with diffuse lesions in his RT PDA , RT LV-VR , LAD , Lcx . 
Given the patient 's symptoms and echocardiographic evidence of cardiomyopathy proceeded the progression of his CAD , it is likely that his arteriosclerosis was not the primary etiology of his imparied cardiac performance though may be contributing to his disease at this time . 
CV/P : CXR on admission revealed pulmonary edema . 
The patient had an excellent reponse to diuresis on lasix and was weaned to room air on the day after admission . 
His home blood pressure medications were continued , and were well controlled . 
A right heart catheterization was performed on 6/3 which showed elevated right and left sided filling pressures , particularly with a Pcw of 24 and mean RA pressure of 5 . 
The patient was started on Imdur during this admission . 
His lisinopril was continued . 
Pt CV/R : Patient is undergoing evaulation for ICD . 
NO ectopy was noted during full-time telemetric monitoring . 
PULM : His OSA was treated with CPAP at 6 cm . 
No active asthma rx . 
No wheezes on exam . 
ENDO : Patient was maintained off his oral medications and placed on insulin alone . 
On admission , his blood sugars were in the 300s . 
His Last A1C was found to be 9.5 . 
While following his blood sugars , his insulin was titrated up and drug therapy discontinued . 
He was discharged with BID NPH insulin to replace his previous med/insulin regimen . 
WSRH outpatient diabetes services follow-up will be arranged for the patient . 
HEME : On coumadin with admit INR 1.1 . 
Coumadin was held during admission and patient instructed to discontinue medication as outpatient considering no hx of afib , LV throbus , or DVT/clot as well as questions with medication compliance . 
F/E/N : Patient was instructed on proper diabetic and HF diet . 
PSYCH/SOCIAL : Hx EtOH abuse , last drink day of admit . 
LFTs were unremarkable . 
Patient also lives with cocaine-using brother hough pt denies use . 
UTox was negative . 
SMC consult provided listing of Spanish AA meetings . 
Social work helped arranged a medical bed for patient at home , and to facilitate his ability to obtain public housing . 
The patient was discharged home in stable condition . 
Followup appts were arranged with his cardiologist , Dr. Myles Mahnken Also , outpatient diabetes management followup will be arranged with the patient by the AHMH Endocrine service . 
He was also instructed to make an appt with his PCP within two weeks . 
VNA services have been obtained to teach and assist him in this new medication changes . . 
ADDITIONAL COMMENTS : STOP taking your coumadin . 
STOP taking your metformin and gliburide . 
CHANGE your insulin to NPH insulin 40 units in the morning and 30 units before bedtime . 
DISCHARGE CONDITION : Stable TO DO/PLAN : follow-up with your cardiologist as instructed . 
No dictated summary ENTERED BY : CURZI , YONG , M.D. -LRB- DO98 -RRB- 8/27/06 @ 02 ****** END OF DISCHARGE ORDERS ****** 
